On the stock market since 2021, it operates in the world of health and science. It has 489 employees. Now — the numbers.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
An investor who bought at the very peak is down 94% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
It pays out $0.03 per share each year — regular cash for whoever holds the stock.
This stock swings about 2 times as much as the market average. Big rallies — and big drops — can both happen fast.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
On our five-subject report card, MDPEF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: MDPEF is a high-risk stock — not yet profitable, and its future rides on its product catching on.